Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine? | אונקוטסט
מאמרים בשיתוף אונקוטסט
מאמרים בשיתוף אונקוטסט
אונקוטסט > מאמרים בשיתוף אונקוטסט > Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?

עדכונים > מאמרים בשיתוף אונקוטסט

Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?

Response to Temozolomide in Patients With Metastatic Colorectal Cancer With Loss of MGMT Expression: A New Approach in the Era of Personalized Medicine?

Shacham-Shmueli et al, 2011 Journal of Clinical Oncology

http://jco.ascopubs.org/content/29/10/e262.full

Authors:

Einat Shacham-Shmueli, Alexander Beny, Ravit Geva, Arye Blachar and Arie Figer, Dan Aderka

צור קשר